• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    France Sleep Apnea Devices Market

    ID: MRFR/HC/43474-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    France Sleep Apnea Devices Market Research Report By Type (diagnostic devices, therapeutic devices) and By End User (home care settings, sleep laboratories hospitals)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    France Sleep Apnea Devices Market Research Report-Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    France Sleep Apnea Devices Market Summary

    The France Sleep Apnea Devices market is projected to grow significantly from 250 USD Million in 2024 to 550 USD Million by 2035.

    Key Market Trends & Highlights

    France Sleep Apnea Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 7.43% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 550 USD Million, indicating robust growth potential.
    • In 2024, the market is valued at 250 USD Million, reflecting the current demand for sleep apnea solutions in France.
    • Growing adoption of advanced sleep apnea devices due to increasing awareness of sleep disorders is a major market driver.

    Market Size & Forecast

    2024 Market Size 250 (USD Million)
    2035 Market Size 550 (USD Million)
    CAGR (2025-2035) 7.43%

    Major Players

    DeVilbiss Healthcare, Cleveland Medical, Somnologica, Fisher and Paykel Healthcare, Sleep Number, Breas Medical, Itamar Medical, Honeywell, LivaNova, NICOX, ResMed, Apex Medical, Z1, Philips Respironics, Medtronic

    France Sleep Apnea Devices Market Trends

    Growing awareness of sleep disorders and the significance of sleep health are driving notable changes in the French sleep apnea devices market. The public's understanding of sleep apnea and the problems it poses is growing as a result of government measures to enhance public health education.

    The French health authorities have been urging patients to seek diagnosis and treatments by focusing on sleep apnea screening and treatment.

    The market for various sleep apnea technologies, including oral appliances and continuous positive airway pressure (CPAP) machines, is being driven by this increasing awareness. The market offers a wealth of chances to investigate, particularly as technology developments enhance the efficacy and comfort of devices.

    Manufacturers now have more options to accommodate patient preferences for tracking and convenience of use thanks to creative designs and the incorporation of smart technology into equipment.

    A handy and less scary option for those who are reluctant to visit sleep clinics, home-based sleep testing is also growing in popularity in France, which is expected to boost treatment rates.

    With an increasing emphasis on individualized treatment regimens for patients with sleep apnea, recent developments point to a push toward personalized medicine. French clinicians are increasingly taking a customized approach, taking into account the needs and preferences of each patient.

    Additionally, telemedicine is becoming more popular since it enables remote monitoring and consulting, which improves patient involvement and treatment compliance. The market for sleep apnea devices is becoming more patient-centered as a result of this confluence of circumstances, which is changing the way sleep apnea is identified and treated throughout France.

    France Sleep Apnea Devices Market Drivers

    Market Segment Insights

    Sleep Apnea Devices Market Type Insights

    The France Sleep Apnea Devices Market is characterized by diverse types of devices tailored to diagnose and treat sleep apnea, reflecting a significant focus on improving patient care in the region. Diagnostic devices are essential in identifying the disorder, employing technologies such as polysomnography and home sleep tests, which facilitate accurate assessment and diagnosis of sleep apnea.

    These devices have gained traction due to the increasing prevalence of sleep disorders among the French population, with awareness campaigns driving early detection.

    On the other hand, therapeutic devices are crucial in managing and treating conditions, with continuous positive airway pressure (CPAP) machines being a dominant solution. The growing emphasis on quality sleep and the rising healthcare expenditure in France are key factors fuelling the demand within this segment.

    Additionally, advancements in technology, including portable devices and innovative treatment options, are reshaping the therapeutic landscape, making treatments more accessible and user-friendly. The market segmentation highlights a strong synergy between diagnostic and therapeutic devices, as timely diagnosis often leads to effective treatment plans, enhancing patient outcomes.

    Furthermore, the collaborative efforts of healthcare professionals and regulatory bodies in France ensure that the latest innovations are integrated into clinical practice, providing significant opportunities for growth in both areas.

    Sleep Apnea Devices Market End User Insights

    The End User segment of the France Sleep Apnea Devices Market includes crucial areas such as home care settings, sleep laboratories, and hospitals, which contribute significantly to the market dynamics. Home care settings are increasingly becoming popular due to the convenience and individual comfort they offer patients, enabling them to manage their conditions in a familiar environment.

    The growing prevalence of sleep apnea in France, coupled with an aging population, underlines the importance of effective home care solutions. Meanwhile, sleep laboratories are essential for comprehensive diagnostic services, playing a vital role in accurately identifying various sleep disorders and leading to tailored treatment plans for patients.

    Hospitals, being at the forefront of healthcare delivery, continue to dominate this segment owing to their capacity to provide advanced technologies and skilled medical personnel.

    The interplay between these settings highlights the market's adaptability to meet diverse patient needs, driven by technological advancements and an increasing focus on patient-centric care. As the France Sleep Apnea Devices Market evolves, the significance of each of these user environments will shape industry trends and growth opportunities.

    Get more detailed insights about France Sleep Apnea Devices Market Research Report-Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The France Sleep Apnea Devices Market has seen significant evolution in recent years, influenced by an increasing awareness of sleep disorders and the expanding healthcare infrastructure.

    Competitive dynamics within this market are shaped by various factors, including technological advancements, the rise in obesity rates, and the aging population, which has contributed to a surge in the demand for effective sleep apnea treatment solutions.

    Moreover, regulatory frameworks and reimbursement policies have contributed to defining the competitive landscape, compelling players to innovate and improve their product offerings.

    The presence of both established and emerging companies has resulted in a dynamic market environment characterized by product diversification and strategic collaborations aimed at harnessing growth potential across various segments, including continuous positive airway pressure devices, oral appliances, and diagnostic equipment.

    DeVilbiss Healthcare has cemented its position in the France Sleep Apnea Devices Market through a robust portfolio of high-quality products and a strong distribution network. The company’s strengths lie in its commitment to innovation and excellence, which is reflected in its wide range of CPAP machines and associated accessories that cater to the varying needs of patients.

    DeVilbiss Healthcare has established a reputation for reliability and effectiveness in its devices, ensuring high patient compliance and satisfaction.

    Additionally, the company's strategic partnerships and collaborations with healthcare providers in France have facilitated a more integrated approach to patient care, contributing to their competitive edge in the market. Their emphasis on customer support and education around sleep apnea management further strengthens their market presence by fostering patient loyalty and trust.

    Cleveland Medical has made notable strides within the France Sleep Apnea Devices Market, characterized by its focus on developing cutting-edge solutions and maintaining a strong market presence. The company specializes in creating innovative devices such as CPAP machines, as well as providing associated services designed to improve patient outcomes.

    Cleveland Medical's strengths include an effective supply chain management system and a keen understanding of local market dynamics, which have enabled them to tailor their products according to the preferences and requirements of French patients.

    The company has also actively pursued strategic mergers and acquisitions, allowing it to expand its market footprint and diversify its product offerings, ultimately enhancing its competitiveness in the region.

    Through ongoing investments in research and development, Cleveland Medical continues to push the envelope in technology and service delivery, positioning itself as a key player in the French sleep apnea market.

    Key Companies in the France Sleep Apnea Devices Market market include

    Industry Developments

    Recent developments in the France Sleep Apnea Devices Market have highlighted significant growth and strategic movements among major players. Companies such as ResMed and Philips Respironics have introduced innovative devices and advanced therapy solutions to cater to a growing patient base, as the prevalence of sleep apnea increases nationwide.

    Developments in digital health solutions have also gained traction, notably with Honeywell's focus on telehealth integration and connected care for patients. In terms of mergers and acquisitions, DeVilbiss Healthcare's acquisition of a small French medical device company in June 2023 signifies a strategic expansion in the local market.

    Additionally, Itamar Medical recently partnered with local distributors to enhance its market reach, effectively broadening access to its diagnostic devices. The French market has seen valuation growth, driven by an increasing awareness of sleep disorders and the need for effective therapies, which is supported by government initiatives targeting sleep health improvements.

    Furthermore, regulatory changes in 2022 aimed at simplifying market access for new medical devices reflect the evolving landscape in France, enhancing opportunities for both existing companies and new entrants in the sleep apnea device sector.

    Market Segmentation

    Sleep Apnea Devices Market Type Outlook

    • diagnostic devices
    • therapeutic devices

    Sleep Apnea Devices Market End User Outlook

    • home care settings
    • sleep laboratorieshospitals

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 232.5(USD Million)
    MARKET SIZE 2024 250.0(USD Million)
    MARKET SIZE 2035 550.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 7.431% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED DeVilbiss Healthcare, Cleveland Medical, Somnologica, Fisher and Paykel Healthcare, Sleep Number, Breas Medical, Itamar Medical, Honeywell, LivaNova, NICOX, ResMed, Apex Medical, Z1, Philips Respironics, Medtronic
    SEGMENTS COVERED Type, End User
    KEY MARKET OPPORTUNITIES Increasing prevalence of sleep apnea, Growing awareness of sleep health, Advancements in wearable technology, Rising demand for home diagnostics, Expansion of telemedicine services
    KEY MARKET DYNAMICS growing prevalence of sleep apnea, increasing awareness and diagnosis, advancements in device technology, rising disposable incomes, supportive healthcare policies
    COUNTRIES COVERED France

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the France Sleep Apnea Devices Market in 2024?

    The France Sleep Apnea Devices Market is expected to be valued at 250.0 USD Million in 2024.

    What will the France Sleep Apnea Devices Market be valued at in 2035?

    By 2035, the France Sleep Apnea Devices Market is projected to reach a valuation of 550.0 USD Million.

    What is the expected CAGR for the France Sleep Apnea Devices Market between 2025 and 2035?

    The expected compound annual growth rate for the France Sleep Apnea Devices Market from 2025 to 2035 is 7.431%.

    How is the France Sleep Apnea Devices Market segmented by type?

    The market is segmented into diagnostic devices, valued at 80.0 USD Million in 2024, and therapeutic devices, valued at 170.0 USD Million in the same year.

    What is the projected market size for diagnostic devices in the France Sleep Apnea Devices Market by 2035?

    The market size for diagnostic devices is expected to grow to 150.0 USD Million by 2035.

    What will the therapeutic devices market size be in 2035?

    The therapeutic devices segment of the France Sleep Apnea Devices Market is anticipated to reach 400.0 USD Million by 2035.

    Who are the key players in the France Sleep Apnea Devices Market?

    Major players in the market include DeVilbiss Healthcare, ResMed, Philips Respironics, and Fisher & Paykel Healthcare.

    Which segment of the France Sleep Apnea Devices Market is expected to see higher growth?

    The therapeutic devices segment is expected to witness higher growth compared to diagnostic devices in the forecast period.

    What are the primary growth drivers for the France Sleep Apnea Devices Market?

    Key growth drivers include increasing prevalence of sleep apnea, rising awareness about sleep disorders, and technological advancements in devices.

    What opportunities exist for new entrants in the France Sleep Apnea Devices Market?

    Emerging trends such as home sleep testing and remote monitoring present significant opportunities for new entrants in the market.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. France
    59. Sleep Apnea Devices Market, BY Type (USD Million)
    60. diagnostic
    61. devices
    62. therapeutic devices
    63. France
    64. Sleep Apnea Devices Market, BY End User (USD Million)
    65. home
    66. care settings
    67. sleep laboratories hospitals
    68. Competitive Landscape
    69. Overview
    70. Competitive
    71. Analysis
    72. Market share Analysis
    73. Major
    74. Growth Strategy in the Sleep Apnea Devices Market
    75. Competitive
    76. Benchmarking
    77. Leading Players in Terms of Number of Developments
    78. in the Sleep Apnea Devices Market
    79. Key developments and
    80. growth strategies
    81. New Product Launch/Service Deployment
    82. Merger
    83. Acquisitions
    84. Joint Ventures
    85. Major
    86. Players Financial Matrix
    87. Sales and Operating Income
    88. Major
    89. Players RD Expenditure. 2023
    90. Company
    91. Profiles
    92. DeVilbiss Healthcare
    93. Financial
    94. Overview
    95. Products Offered
    96. Key
    97. Developments
    98. SWOT Analysis
    99. Key
    100. Strategies
    101. Cleveland Medical
    102. Financial
    103. Overview
    104. Products Offered
    105. Key
    106. Developments
    107. SWOT Analysis
    108. Key
    109. Strategies
    110. Somnologica
    111. Financial
    112. Overview
    113. Products Offered
    114. Key
    115. Developments
    116. SWOT Analysis
    117. Key
    118. Strategies
    119. Fisher and Paykel Healthcare
    120. Financial
    121. Overview
    122. Products Offered
    123. Key
    124. Developments
    125. SWOT Analysis
    126. Key
    127. Strategies
    128. Sleep Number
    129. Financial
    130. Overview
    131. Products Offered
    132. Key
    133. Developments
    134. SWOT Analysis
    135. Key
    136. Strategies
    137. Breas Medical
    138. Financial
    139. Overview
    140. Products Offered
    141. Key
    142. Developments
    143. SWOT Analysis
    144. Key
    145. Strategies
    146. Itamar Medical
    147. Financial
    148. Overview
    149. Products Offered
    150. Key
    151. Developments
    152. SWOT Analysis
    153. Key
    154. Strategies
    155. Honeywell
    156. Financial
    157. Overview
    158. Products Offered
    159. Key
    160. Developments
    161. SWOT Analysis
    162. Key
    163. Strategies
    164. LivaNova
    165. Financial
    166. Overview
    167. Products Offered
    168. Key
    169. Developments
    170. SWOT Analysis
    171. Key
    172. Strategies
    173. NICOX
    174. Financial
    175. Overview
    176. Products Offered
    177. Key
    178. Developments
    179. SWOT Analysis
    180. Key
    181. Strategies
    182. ResMed
    183. Financial
    184. Overview
    185. Products Offered
    186. Key
    187. Developments
    188. SWOT Analysis
    189. Key
    190. Strategies
    191. Apex Medical
    192. Financial
    193. Overview
    194. Products Offered
    195. Key
    196. Developments
    197. SWOT Analysis
    198. Key
    199. Strategies
    200. Z1
    201. Financial
    202. Overview
    203. Products Offered
    204. Key
    205. Developments
    206. SWOT Analysis
    207. Key
    208. Strategies
    209. Philips Respironics
    210. Financial
    211. Overview
    212. Products Offered
    213. Key
    214. Developments
    215. SWOT Analysis
    216. Key
    217. Strategies
    218. Medtronic
    219. Financial
    220. Overview
    221. Products Offered
    222. Key
    223. Developments
    224. SWOT Analysis
    225. Key
    226. Strategies
    227. References
    228. Related
    229. Reports
    230. LIST
    231. OF ASSUMPTIONS
    232. France Sleep Apnea Devices Market SIZE
    233. ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    234. France
    235. Sleep Apnea Devices Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035
    236. (USD Billions)
    237. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    238. ACQUISITION/PARTNERSHIP
    239. LIST
    240. Of figures
    241. MARKET SYNOPSIS
    242. FRANCE
    243. SLEEP APNEA DEVICES MARKET ANALYSIS BY TYPE
    244. FRANCE SLEEP
    245. APNEA DEVICES MARKET ANALYSIS BY END USER
    246. KEY BUYING
    247. CRITERIA OF SLEEP APNEA DEVICES MARKET
    248. RESEARCH PROCESS
    249. OF MRFR
    250. DRO ANALYSIS OF SLEEP APNEA DEVICES MARKET
    251. DRIVERS
    252. IMPACT ANALYSIS: SLEEP APNEA DEVICES MARKET
    253. RESTRAINTS
    254. IMPACT ANALYSIS: SLEEP APNEA DEVICES MARKET
    255. SUPPLY /
    256. VALUE CHAIN: SLEEP APNEA DEVICES MARKET
    257. SLEEP APNEA DEVICES
    258. MARKET, BY TYPE, 2024 (% SHARE)
    259. SLEEP APNEA DEVICES MARKET,
    260. BY TYPE, 2019 TO 2035 (USD Billions)
    261. SLEEP APNEA DEVICES
    262. MARKET, BY END USER, 2024 (% SHARE)
    263. SLEEP APNEA DEVICES
    264. MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    265. BENCHMARKING
    266. OF MAJOR COMPETITORS

    France Sleep Apnea Devices Market Segmentation

    • Sleep Apnea Devices Market By Type (USD Million, 2019-2035)

      • diagnostic devices
      • therapeutic devices
    • Sleep Apnea Devices Market By End User (USD Million, 2019-2035)

      • home care settings
      • sleep laboratories hospitals
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials